Form 8-K Kite Pharma, Inc. For: Aug 17
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Standpoint Research Starts Kite Pharma (KITE) at Buy
August 17, 2015 9:42 AM EDTStandpoint Research initiated coverage on Kite Pharma (NASDAQ: KITE) with a Buy rating and a price target of $100.00.
For an analyst ratings summary and ratings history on Kite Pharma click here. For more ratings news on Kite Pharma click here.
Shares of Kite Pharma closed at $58.00 yesterday.
... More


